Skip to content
Descubridor Institucional UMAR
Inicio
Búsqueda avanzada
Explorar
Inicio
Búsqueda avanzada
Explorar
Login
Language
English
Deutsch
Español
Français
Italiano
All Fields
Title
Author
Subject
Call Number
ISBN/ISSN
Tag
Find
Advanced
Time to Recognise Psoriasis as a Cardiovascular Risk Modifier in National Guidance
Time to Recognise Psoriasis as a Cardiovascular Risk Modifier in National Guidance
Fuente:
Wiley Open Access
Saved in:
Bibliographic Details
Main Authors:
Annika Smith
,
John Frew
Format:
Artículo Open Access
Published:
Wiley
2025
Subjects:
Australasian Journal of Dermatology
Online Access:
Acceder al recurso
Tags:
Add Tag
No Tags, Be the first to tag this record!
Cite this
Text this
Email this
Print
Export Record
Export to RefWorks
Export to EndNoteWeb
Export to EndNote
Save to List
Permanent link
Holdings
Description
Comments
Similar Items
Staff View
Be the first to leave a comment!
Your Comment
You must be logged in first
Similar Items
Improving Cardiovascular Outcomes in the Psoriasis Cohort. Psoriasis and Cardiovascular Disease–Patient Knowledge, Perspectives and Practice
by: Annika Smith, et al.
Published: (2025)
Improving Cardiovascular Outcomes in the Psoriasis Cohort. Psoriasis and Cardiovascular Disease—Clinician Knowledge, Practice and Perceptions
by: Annika Smith, et al.
Published: (2025)
‘Psoriasis Punctata’: An Under‐Recognised Clinical Phenotype of TNF‐Alpha Inhibitor‐Induced Psoriasis
by: Grace Im, et al.
Published: (2025)
Paediatric Psoriasis and the Topical Treatment Guidance Gap in Australia
by: James Gaston, et al.
Published: (2026)
New‐Onset Vitiligo and Change in Disease Status Following COVID ‐19 Vaccination and COVID ‐19 Infection—An Online Survey
by: Raaisa Islam, et al.
Published: (2025)
